Author

Patrick J. Stiff

Institutions: Loyola University Medical Center, Loyola University Chicago, Loyola Medicine

Observed institutions: University of North Carolina at Chapel Hill, Loyola University Medical Center, Mayo Clinic, Loyola University Chicago, Medical College of Wisconsin, Princess Margaret Cancer Centre, Loyola Medicine, U-M Rogel Cancer Center, Case Western Reserve University

OpenAlex ID: A5124947741

High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Ovarian Cancer: An Autologous Blood and Marrow Transplant Registry Report

2000 · Patrick J. Stiff, Judith Veum-Stone, et al. · Annals of Internal Medicine · 54

Outcomes of an Alpha-DC-1 Dendritic Cell-Based Vaccine Clinical Trial in Patients with Low-Tumor-Burden High-Risk Ovarian Carcinoma

2026 · Patrick J. Stiff, Cheryl M. Czerlanis, et al. · Cancers · 3

Phase 1 dose escalation study of CD34 selected CD19 directed CAR T with metabolic programming in relapsed/refractory B-cell lymphoma.

2026 · Brian Hess, Elizabeth Goodwin Hill, et al. · Journal of Clinical Oncology

Frequency of and Risk Factors for Thromboembolism and Major Bleeding in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation

2026 · Alexander O'Hara, Abhilasha Kumar, et al. · Transplantation and Cellular Therapy

Evaluating GVHD Outcomes after Chemotherapy-Only Conditioning in Nicotinamide Expanded Umbilical Cord Blood (omidubicel) Transplantation: A Retrospective cohort study

2026 · Abhilasha Kumar, Alexander O'Hara, et al. · Transplantation and Cellular Therapy

QTc Prolongation in Allogeneic Bone Marrow Transplantation: Assessing Cardiac Complications and Survival Outcomes in the Modern Era

2026 · Mark deBettencourt, Timothy E O'Connor, et al. · Transplantation and Cellular Therapy

Works count: 6

Citation count: 57

H-index: 2

I10-index: 1